Concepedia

Amber D. Bowler

AD

8

Publications

635

Citations

8

H-Index

2015

Active since

Affiliations

Huntsman Cancer Institute(Current)

University of Utah

École Polytechnique Fédérale de Lausanne

Oregon Health & Science University

Tsinghua University

Amber D. Bowler is an author at Huntsman Cancer Institute specializing in medicine, tumor biology, and oncology.

ORCID

Top concepts

Publications per year

2015–2024

8

Publications

8

Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

Christopher A. Eide, Matthew S. Zabriskie, Samantha L. Savage et al. · Cancer Cell · 2019 · 239 citations · Full text

, , +8

Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of <scp>TGF</scp> β

Markus Germann, Nadine Zangger, Marc‐Olivier Sauvain et al. · EMBO Molecular Medicine · 2019 · 161 citations · Full text

Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo

L. Francisco Lorenzo‐Martín, Tania Hübscher, Amber D. Bowler et al. · Nature · 2024 · 81 citations · Full text

shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance

Jamshid S. Khorashad, Anna M. Eiring, Clinton C. Mason et al. · Blood · 2015 · 44 citations · Full text

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

Anna M. Eiring, Jamshid S. Khorashad, David Anderson et al. · Leukemia · 2015 · 42 citations · Full text

, , +6

Rows per page

1–5 of 8